Sixth fertility and sterility congress--a review.
D001695:Biology; D002715:Chlormadinone Acetate; D002996:Clomiphene; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003300:Copper; D004194:Disease; D004617:Embolism; D004703:Endocrine System; D004967:Estrogens; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006728:Hormones; D015994:Incidence; D007239:Infections; D007267:Injections; D007434:Intrauterine Devices; D017258:Medroxyprogesterone Acetate; D008599:Menstruation Disturbances; D009644:Norgestrel; D000292:Pelvic Inflammatory Disease; D010827:Physiology; D045167:Progesterone Congeners; D011800:Quinestrol; D012106:Research; D012107:Research Design; D013812:Therapeutics; D013923:Thromboembolism; D013995:Time; D014595:Uterine Perforation; D014652:Vascular Diseases; D015032:Zinc
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens; D006728:Hormones; D045167:Progesterone Congeners; D002715:Chlormadinone Acetate; D002996:Clomiphene; D009644:Norgestrel; D003300:Copper; D017258:Medroxyprogesterone Acetate; D015032:Zinc; D011800:Quinestrol
Biology; Chlormadinone Acetate--administraction and dosage; Chlormadinone Acetate--side effects; Clomiphene; Contraception; Contraceptive Agents, Estrogen; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Contraceptive Effectiveness; Contraceptive Methods; Contraceptive Methods--complications; Contraceptive Methods--side effects; Copper; Diseases; Embolism; Endocrine System; Estrogens; Family Planning; Hormones; Incidence; Infections; Injectables; Insertion; Iud Material; Iud, Unmedicated; Iud--complications; Literature Review; Longterm Effects; Measurement; Medroxyprogesterone Acetate--administraction and dosage; Medroxyprogesterone Acetate--side effects; Menstruation Disorders; Norgestrel--administraction and dosage; Norgestrel--side effects; Oral Contraceptives, Combined--side effects; Oral Contraceptives, Low-dose; Oral Contraceptives--side effects; Pelvic Infections; Perforations; Physiology; Progestins, Low-dose; Quinestrol--administraction and dosage; Quingestanol Acetate--administraction and dosage; Research Methodology; Thromboembolism; Treatment; Use-effectiveness; Uterine Perforation; Vascular Diseases; Zinc